M&T Bank
ACHN

M&T Bank’s Achillion Pharmaceuticals ACHN Stock Holding History

M&T Bank’s Portfolio ACHN Stock Details ACHN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-16,330
Closed -$145K – 2096
2015
Q2 		$145K Buy
16,330
+3,350
+26% +$31.7K ﹤0.01% 1836
2015
Q1 		$128K Hold
12,980
– – ﹤0.01% 1829
2014
Q4 		$159K Sell
12,980
-2,970
-19% -$36.3K ﹤0.01% 1820
2014
Q3 		$159K Buy
+15,950
New +$148K ﹤0.01% 1947

Other funds holding ACHN

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

M&T Bank's ACHN Position: Q3 2015 in Review

M&T Bank sold out of Achillion Pharmaceuticals (ACHN) in Q3 2015, closing a stake of 16,330 shares — an estimated $145K sold.

M&T Bank first reported a position in ACHN in Q3 2014 and held it in 4 quarters. The position peaked at $159K in Q4 2014. 141 funds tracked by Wall St. Rank hold ACHN as of Q3 2015.

  • M&T Bank reported no remaining Achillion Pharmaceuticals position as of Q3 2015 after selling out during the quarter.
  • M&T Bank sold 16,330 Achillion Pharmaceuticals shares in Q3 2015, an estimated $145K.
  • M&T Bank first reported a position in Achillion Pharmaceuticals in Q3 2014 and held it in 4 quarters.
  • M&T Bank's Achillion Pharmaceuticals position peaked at $159K in Q4 2014.
  • 141 funds tracked by Wall St. Rank held Achillion Pharmaceuticals as of Q3 2015.

Based on M&T Bank's 13F filing for Q3 2015, filed 13 Nov 2015.